NASDAQ RESUMED AT 10:24 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:19 AM
Niki BioSolutions weighs financing options as going-concern warning clouds post-merger outlook
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 09:01 PM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Aptorum Group Limited Announces Receipt Of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Brief: Aptorum Group Limited Announces Up To $6 Million Registered Direct Offering
Brief: Aptorum Group Limited And DiamiR Biosciences Enter Into Definitive Merger Agreement
Brief: Aptorum Group Limited Reports Financial Results And Business Update For The Six Months Ended June 30, 2024
On March 6, Entered Into Agreement And Plan Of Merger, Dated March 1, With Yoov Group Holding Limited
Brief: Aptorum Group To Merge With Business AI Platform YOOV Group
Brief: Aptorum Group Receives Nasdaq Approval To Transfer Listing To Nasdaq Capital Markets
Brief: Nasdaq Notified Aptorum Group It Would Have Until October 2 To Regain Compliance With Rule
Brief: Aptorum Therapeutics Ltd Enters Into Letter Of Intent And Term Sheet With Universal Sequencing Technology Corp To Merge With Aptorum Group's Subsidiary Paths Innovations Ltd
Brief: Aptorum Group Enters Into Letter Of Intent And Term Sheet To Acquire U Group
Brief: Aptorum Group Announces Completion Of Pre-Ind Discussions With FDA On Its Drug Als-4 Targeting Methicillin Resistant Staphylococcus Aureus
Brief: Aptorum Group Ltd Completion Of End Of Phase 1 Meeting With US FDA On Its Sact-1 Drug Targeting Neuroblastoma